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ABSTRACT
Objective: This study explored National Health Service
(NHS) pharmacists’ perceptions and experiences of
pharmacist-led research in the workplace.
Design: Semistructured, face-to-face discussions
continued until distinct clusters of opinion
characteristics formed. Verbatim transcripts of audio-
recordings were subjected to framework analysis.
Setting: Interviews were carried out with 54
pharmacists with diverse backgrounds and roles from
general practices and secondary care in the UK’s
largest health authority.
Results: The purpose and potential of health services
research (HSR) was understood and acknowledged to
be worthwhile by participants, but a combination of
individual and system-related themes tended to make
participation difficult, except when this was part of
formal postgraduate education leading to a
qualification. Lack of prioritisation was routinely cited
as the greatest barrier, with motivation, confidence and
competence as additional impediments. System-related
themes included lack of practical support and
pharmacy professional issues. A minority of highly
motivated individuals managed to embed research
participation into routine activity.
Conclusions: Most pharmacists realised the
desirability and necessity of research to underpin
pharmacy service expansion, but a combination of
individual and professional level changes is needed to
increase activity. Our findings provide a starting point
for better understanding the mindset of hospital-based
and general practice-based pharmacists towards
research, as well as their perceived barriers and
supports.
INTRODUCTION
Health Services Research (HSR) is a multidis-
ciplinary approach to identifying effective
ways to organise/manage/ﬁnance and deliver
high-quality care, reduce medical errors and
improve patient safety.1 It can provide an
evidence base for appropriate, targeted, cost-
effective, efﬁcient and acceptable services.2
Changes to the structure and function of
healthcare services, including pharmacists’
roles responding to patient need,3 4 have led
to calls for increased HSR activity among
pharmacists,2 5–10 particularly in the UK.11 12
Rigorous pharmacy-led HSR underpins
several pharmacy services.13–20 Neutral ﬁnd-
ings consolidate the status quo21 and nega-
tive results can signal directional
changes.22 23 However, these examples are
few relative to the number of services deliv-
ered routinely by pharmacists in settings
where the status quo may not be ideal.24 The
lack of empirical evidence for pharmacy ser-
vices may be seen as an impediment to pro-
gress.25 Beneﬁts for improving research into
pharmacy services include patient outcomes,
Strengths and limitations of this study
▪ We selected a diverse sample of pharmacists
from the largest health board in the UK.
▪ Semistructured discussion schedules gave parti-
cipants a platform to follow their own interests;
present contrary views; and generate new data,
while use of the framework enabled a review of
interpretations through a systematic approach.
▪ Themes of motivation and a need for practical
support were so persistent that we are confident
that we captured common aspects of pharma-
cists' perceptions and experiences of research.
▪ Our findings provide a starting point for better
understanding the mindset of hospital-based and
general practice-based pharmacists towards
research, as well as their perceived barriers and
supports.
▪ There may have been an implicitly positive view
of research in the questioning, particularly as
pharmacists were asked, in general, why they
had not participated.
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encouraging multidisciplinary teamworking, improving
the knowledge/visibility of services and provide a wider
view on patient care and how pharmacy ﬁts within
that.26 Evaluations have concluded that research in
pharmacy is lacking in terms of community pharmacy
service impact on health promotion and disease
management.27
In the UK, the three main areas in which pharma-
cists work are in community pharmacy, hospital and
general practice (primary care)28; and proportions
undertaking research are unknown.29 Community phar-
macies are independent contractors and act on behalf
of the National Health Service (NHS) for the provision
of NHS prescriptions and other services. Hospital-based
and general practice-based pharmacists differ from
community pharmacists in that they are employed
directly by the NHS, based in hospitals or general
practices, working within multidisciplinary teams of
healthcare professionals, have career pathways deﬁned
by NHS job roles and research is included in their
job roles.
The various areas of career progression in NHS phar-
macy are based on specialist knowledge and experience.
Within pharmacy in the UK NHS hospitals and general
practices, the career structure begins at a band 6 general
pharmacist. Progression into a higher band ﬁrst requires
a vacancy in that band, and to be eligible to apply for
the vacancy, the pharmacist must possess a higher level
of training (qualiﬁcations), skills and experience.30
Moving up to a higher band can be achieved without
undergoing training or developing skills and experience
in research.31 While research participation forms part of
the job description of NHS employee pharmacists,32
other than voluntary pursuance of some postgraduate
qualiﬁcations, there is no external pressure to conduct
research. Few NHS pharmacists are thought to partici-
pate in research and the reasons for this are poorly
understood. Reasons for community pharmacists not
participating in research include a lack of time,33–41
expertise,25 26 28 monetary reimbursement,27 prioritisa-
tion and management support.42
Previous research has suggested that these differences
result in enablers and barriers, which are unique to the
experiences of community pharmacists, and therefore
have limited analytical or theoretical extrapolation to
NHS employee pharmacists practising in hospitals and
general practices.11 12 29 We therefore chose to focus on
NHS employee pharmacists in this study.
Given the need to ensure optimal use of NHS
resources and demonstrate the efﬁcacy of delivered
models of care, pharmacists’ participation in research in
the NHS is necessary and desirable. With a lack of
research into the effectiveness of pharmacy services
within healthcare, there may be a suggestion that phar-
macists are reluctant to develop and implement research
ideas. We aimed to explore factors inﬂuencing research
participation by NHS pharmacists in the largest NHS
health board in Scotland, UK.
METHODS
Following piloting and modiﬁcation, a ﬂexible semistruc-
tured discussion schedule was developed for interviews.
Initially, ﬁve NHS Greater Glasgow and Clyde (GGC)
pharmacists from different sectors and with different
levels of research experience were approached. Using
these ﬁve pharmacists, we identiﬁed more participants
to achieve a maximum variation sample.43 For pragmatic
reasons, we used a chain referral recruitment strategy,
where research participants were asked to identify add-
itional potentially suitable participants.44 We approached
pharmacists with a range of roles, years qualiﬁed, level
of seniority and experience of research. All those identi-
ﬁed were telephoned and agreed to participate in this
service evaluation. The GGC Ethics Committee
Scientiﬁc ofﬁcer deemed that the study could proceed
without Ethical Committee consideration and manage-
ment approval was obtained.
On the basis of qualitative pooling data and expert
opinion,45 we aimed to recruit between 30 and 60 parti-
cipants to ensure consistency across questions asked. We
concluded recruitment when we felt this point was
reached.
Participants agreed on a convenient time and location
for face-to-face interviews with (RL and GM), lasting
between 20 and 90min.
PROCEDURE
It was explained to each pharmacist that the reason for
the interview was to explore their personal views and
experiences of HSR and to consider factors that may
hinder or support participation. Respondents’ identities
were anonymised prior to analysis.
All interviews were audio-recorded, anonymised and
transcribed verbatim by an independent researcher
(MS) and checked for accuracy/completeness by the
interviewer. We took an inductive approach to analysis
but utilised our sampling criteria, research questions
and a priori codes to inform the coding frame and
index to analyse the data. An inductive approach
together with a priori concepts informed the search for
associations and the understanding of ﬁndings.46
Framework analysis began after transcripts were
checked, involving GM, RL and HT: noting initial ideas
directly onto the transcripts and indexing interesting
and relevant features of the data. Transcripts were then
uploaded to text management software (NVIVO V.10,
QSR 2012) where data were categorised, sorted and
organised to enable application of initial codes across
interviews which were then collated into potential
themes.47 Discussions were analysed separately and then
compared for experiences, beliefs and attitudes. Patterns
of data were formed into concepts and themes, through
checking and interpretation of agreed themes applied
across different transcripts (see online supplementary
appendix).48 Data were subjected to cross-sectional the-
matic analysis.49 50 Interim thematic maps were created,
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reviewed and revised by RL, GM and HT. Reﬁnement
continued until clear deﬁnitions, names and a hierarch-
ical structure were agreed on. Interpretation differences
were resolved collectively. Interviews continued until RL,
GM and HT felt that no more new themes of relevance
to the research question were emerging and they had a
reasonable collection of views across the various attri-
butes of pharmacists.
Sample quotations are given under thematic headings
to express a range of perceptions and experiences that
were deemed to be of relevance to the research objec-
tives. Where multiple examples of a shared view or
experience were expressed, we selected some based on
their level of lucidity. Deviating accounts were also
included under thematic headings to adequately reﬂect
diversity (see online supplementary appendix). Results
are also summarised as frequency tables of themes
reported across the different areas of practice, years
qualiﬁed and involvement in research.
FINDINGS
Themes and detailed characteristics were established
after 54 interviews. These were conducted between 23
August 2013 and 13 March 2014. The characteristics of
participating pharmacists are described below (table 1).
CHARACTERISTICS OF PARTICIPANTS
Themes and detailed characteristics were established
after 54 interviews. These were conducted between 23
August 2013 and 13 March 2014. The characteristics of
participating pharmacists are described below (table 1).
Participants were predominantly female, varying in
NHS setting and research experiences. The majority
were over 10 years qualiﬁed. Approximately equal
numbers practised in hospital or primary care (general
practice). Less than half declared engagement in
research activity at the time of the interview, and of
those, the majority were involved in research connected
to a postgraduate degree (either their own or supervis-
ing others). Three declared involvement in research
that was not linked to a formal qualiﬁcation. In almost
all of those not currently involved but who had had pre-
vious research experience, the previous experience was
in connection with personal postgraduate education.
Five participants had never been involved in any form of
research.
UNDERSTANDING OF RESEARCH
While most viewed HSR as a powerful tool for service
change, there were a range of views about the purpose
of research. Many had been involved in audit and it was
sometimes challenging to distinguish differences
between audit and research. Often, research experience
was gained via the process of academic qualiﬁcations
and as such was characterised as a ‘means to an end’.
Participants were asked to describe what they felt con-
stituted HSR. Some pharmacists experienced difﬁculty
distinguishing between different forms of investigation:
Research within the NHS…? Probably… traditionally, as a
pharmacist… audit… service development, em…
nothing necessarily high proﬁle. (P38)
However, most pharmacists articulated the role of
research in terms of adoption of learning across a wider
audience and generation of an evidence base for phar-
macy services, though some questioned their engage-
ment in ‘proper research’:
Things that go on for years having an outcome which
might or might not inﬂuence practice. So I guess that is
what I think of initially when I think of research. (P10)
If you’re without good research you can’t progress your
service. (P43)
I’ve been involved in quite a lot of audit, but probably
not anything that you would classify as proper research.
(P51)
Table 1 Research-related characteristics of 54
participating pharmacists
Characteristic N (%)*
Gender
Female 37 (68)
Years qualified
1–10 11 (20)
11–20 13 (25)
21–30 17 (31)
31+ 13 (24)
Sector of work
Hospital 19 (36)
Primary care 21 (39)
Public health 3 (5)
Mental health/addictions 5 (10)
Education and training 3 (5)
Other 3 (5)
Research activity
Current 20 (37)
Postgraduate pharmacy education 12/20 (60)
Pre-registration pharmacist project 5/20 (25)
HSR unrelated to qualification 3/20 (15)
No current; previous only 29 (54)
Postgraduate pharmacy education 27/29 (93)
Other 2/29 (7)
Years since previous activity
1–5 16/29 (55)
6–10 5/29 (17)
11–15 2/29 (7)
≥15 6/29 (21)
No current or previous activity 5 (9)
*Expressed as proportion of 54 participants unless stated
otherwise.
HSR, health services research.
Lowrie R, et al. BMJ Open 2015;5:e009180. doi:10.1136/bmjopen-2015-009180 3
Open Access
Well, I think if we are going to survive as a profession we
have to have [research]. We have to develop as a profes-
sion. (P12)
It’s that classic line, ‘audit is making sure we’re doing the
thing right and research is about doing the right thing’.
(P33)
[Research is about developing] a better way of working
to achieve the objective of improving healthcare of
patients. (P35)
In the context of my work I would imagine research is
looking into why we do what we do. Em… I’m imagin-
ing… how we can do things better, what we can learn
from what we’re doing, understanding why we do some-
thing… (P21)
Audits are very good for speciﬁc local areas, but to be
able to apply it to a wider… you’d need the evidence
base from research to be able to prove that. (P52)
Much of the interview discussion centred on the bar-
riers to being research active and the key themes are
grouped around ‘individual elements’ and ‘contextual
domain’.
Three distinct themes emerged which were directly
located within the individual: motivation, personal pro-
fessional factors and conﬁdence/competence. Together,
these appeared to contribute much to an individual’s
likelihood of interacting with research and the research
process.
INDIVIDUAL ELEMENTS
Motivation
Active engagement in research is set out as a part of the
role and remit of pharmacists working in the UK NHS.
Interviewees, however, typically saw research as an activ-
ity that involved substantial personal cost for limited per-
sonal gain. Pharmacists did not describe external drivers
but instead focused on personal motivation (or lack
thereof) when discussing participation in research. For
many, previous research activity was conﬁned to post-
graduate study and that experience was rarely positive.
Nevertheless, the inherent value of research, in abstract
terms, was frequently mentioned, though there was little
desire to ‘gamble’ on research that may result in nega-
tive outcomes and few were willing to assume principal
investigator roles. When research was valued, intervie-
wees recognised the worth it demonstrated:
It’s become clearer and clearer is that we need to do a
lot more practical research to make sure that we’re giving
the best care to patients and my main role now is to
improve the quality of care. (P8)
Motivations despite having a positive impact on
involvement in research were affected by barriers. There
was a fear, feeling of no support and going against the
culture hindering practice improvement:
I want to deliver something quickly and relatively easily,
so I don’t want to do a full-blown research project
around it. I just want to do it and get it done because
I’ve messed about with it for a few months. (P12)
PERSONAL PROFESSIONAL FACTORS
Pharmacists acknowledged the importance of research
to their professional standing and potential for contribu-
tion to patient care. However, a lack of time or prioritis-
ing their immediate, core daily clinical activities
explained the low rates of participation for many.
I think people in the past have seen research as interest-
ing, good to do, but don’t have the time. (P8)
[Research is] just not seen as part of the job, part of the
routine job, of the pharmacy… I’m aware of the pres-
sures… the management pressures. (P3)
You are getting paid to deliver a service. So you don’t
give [research] priority, therefore, you don’t do it. (P41)
What they were doing was, essentially, a ﬁshing exercise
to see if they could ﬁnd a research question. I don’t
particularly want to be wasting time doing stuff like
that. (P7)
A few sufﬁciently internally motivated pharmacists
prioritised research, changing their working practices to
enable research to take place. Conducting research
within regular hours was seen as a luxury for most. This
meant that for some, research had to compete with
other demands within the work–life balance
conundrum.
Even maybe just ﬁtting it in to your normal job would be
challenging if you have a topic or something that you
were wanting to look into you would have to, sort of,
work out how you were going to do it along with your
other job. (P15)
I’m taking every second Friday off as annual leave to
work on [my MSc]… I haven’t got the time in work… I
just kind of assumed it had to be your own time… You
do get study leave… I haven’t thought about study leave
for this… (P24)
What I’ve done is I’ve agreed with [my manager] to work
the compressed hours so 4 days a week which would
free up a day [for research]… not formalised but
agreed. (P17)
I think if you become so interested in [a research topic]
you can often ﬁnd [the means] to make it happen… so I
don’t think there any major barriers to doing [research].
I think it would work as long as I was really interested
in it… You tend to be able to create time when you
have to. (P39)
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I think once I’ve had a break [I would consider project
work] because I think it does massively disrupt your per-
sonal life, I would say. (P30)
Responding to immediate patient care and service
needs dominated pharmacists’ minds and daily activities,
making the long-term gain and prospects of developing
an evidence base for service change relatively less
important. Research inactivity was seen by some as a
more general problem across the NHS, where system
pressures force a focus on immediate tasks rather than
longer term impacts. A consensus appeared to emerge
on the need for protected time for research with add-
itional funding key to ensure continuity of delivery of
existing roles through backﬁll arrangements; suggesting
that a pharmacy culture change is required.
Nevertheless, this ‘priorities’ barrier may be based
around a personal preference or just holding out for the
right project to grab their attention rather than the
service:
It would have to be something that was relevant to my
current work and it think then they probably would be
fairly supportive. (P33)
It would seem that in order to overcome priorities,
either perceived by the service or personal commit-
ments, research projects have to be targeted at the inter-
ests and career of the right pharmacist as well as the
potential beneﬁt to the service in question.
COMPETENCE AND CONFIDENCE
Several participants conﬁded that they did not perceive
themselves to have the required knowledge and skills to
enable research participation. Such skills were rarely
required in routine core roles and interviewees felt that
any skills they may possess would be quickly lost if not
used regularly. Given that most pharmacists’ experience
of research was judged to be ‘low level’, a preference for
undertaking small studies could be consolidated to build
overall capacity and, crucially, conﬁdence was exposed.
Interviewees were fearful of their ideas being dismissed
and there was a ‘fear’ of entering into the ‘unknown’.
This fear of the unfamiliar was coupled with expecta-
tions that research would be completely independent
work:
It scares me a bit, research…(1) I am not sure if my
brain works in the right way and (2) The lack of experi-
ence in it and knowing what or how to do it, and how to
do it properly… I suppose my experience and lack of
exposure of having to do things myself is an issue and
that is one of the reasons why I probably wouldn’t go
down that route because I don’t feel comfortable. (P10)
Generating research ideas was particularly problematic
and the perceived inability to develop a good idea
appears to stiﬂe research. Experience appeared to
mediate this concern and interviewees with a
postgraduate qualiﬁcation were more likely to be
involved in research (ie, within 1–5 years; table 2).
However, these deterrents were referred to as false
reasons for preventing participation by a few intervie-
wees. With encouragement, many pharmacists believe
that research would grow within the profession:
I think if it (research) was a bit less like that (‘MSc is
quite a solitary thing’) and a bit more of a team involve-
ment, I wouldn’t have any objections to being involved in
(research). (P16)
Paradoxically, experiences of research during the
pursuit of postgraduate qualiﬁcation (which is often
necessary for career progression within the NHS) sug-
gested that it acted as a disincentive for research in the
workplace:
[Research] is just is not on my radar, to be brutally
honest. I’d rather just go out there and do what I have to
do and try to develop what we’re doing… Maybe I’m
being coloured by bad guidance or leadership back at
the time when I was doing [my MSc]. (P11)
I think some people might be like “that [MSc in clinical
pharmacy] was awful, I would never do that again” or “I
wish I never did that. (P30)
I guess my exposure to [research] has been to do with
further education etc, rather than properly integrated
into the heart of what you do as your work. I guess, in my
head, I probably have seen it as a separate entity, which I
know it shouldn’t be… (P10)
It took a lot of my time, you know, I… for six months
probably had to give up most evenings. Probably not
that… until the last three months I didn’t have to give up
so many weekends. I wouldn’t be overly enthralled at the
idea of doing that again, particularly, if there wasn’t a
qualiﬁcation at the end of it for me, which is probably a
bit selﬁsh, but it was a lot of time. (P16).
Contextual domain
As well as individual level inﬂuences on research partici-
pation, the environment or context in which pharma-
cists are is equally important. Key among those was the
structure or professional hierarchy together with the
ability to engage with research experienced colleagues.
PRACTICAL SUPPORT
Participants acknowledged the need for support, particu-
larly during the early stages of the research process. The
need for research networks and peer support were also
highlighted, given that many individuals perceived them-
selves to be isolated from research active peers:
I think it is quite hard for people to come up with
[research topics] in isolation. I think if you get people in
a group and they say “Oh, you thought of that, oh right,
ok” and then feed off each other and maybe come up
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with what the barriers are and they might come up with
a few really good ideas to come up with to drive
forward… [Mentors] would be needed as part of the
formula [to engage pharmacists in research]… just to be
able to bounce off someone there for a bit of practical
support, to keep the whole thing having a bit of momen-
tum behind it. (P23)
For some, having learnt from mistakes made within a
postgraduate qualiﬁcation context, accessing the right
support at the right time was seen as critical. Pharmacists’
concerns around research knowledge and expertise
together with a lack of conﬁdence translated into expres-
sions of the need for help and assistance from colleagues:
I probably would be happy to lead on something if I
knew I had the support of a team and it wasn’t just me
doing something. (P16)
The idea of a centralised research support facility was
considered as an answer to the overwhelming need for
research guidance on a diverse range of issues, including
protocol development, funding, ethics approval and stat-
istical analysis, to name but a few:
If you had a centralised body where someone would say
“I’ve got this idea, it might be a bit mad”, talking it
through with somebody and then it’s passed as a good
idea and it’s actually aligned to the direction of the
organisation or something that’s strategically important…
but then the organisation can support that by putting a
collective of people together, or perhaps directing them
towards resource that might be external as well as
internal, to allow it to be realised. Some nominal central-
isation where there’s maybe an initial screening of an
idea. And at that point you could either have a local
support network or if it’s something that centrally seems
to be very important then you could coordinate the
degree of support or resources allocated from a central
perspective. (P1)
Acknowledging a lack of research leadership, one par-
ticipant stated the case for job roles which oversee
research activity within each site:
I think within each of our teams, our sites, you know, we
should have 2 or 3 people—I mean, I think everybody
should be involved, but I think within each site, within
each hospital, within each team, prescribing support, etc,
there should be 2 or 3 people with a, kind of, responsibil-
ity for overseeing research projects in that team and
everybody within the team should have some kind of
input and responsibility. Because if you don’t have the
people to make it happen, then it won’t happen. (P42)
One individual suggested a database of research activ-
ity, which could be used to match pharmacists with
potential collaborators:
I mean the thing is if you have somewhere where you go
and have a look and see what has been done previously…
and then if you saw something similar to what you were
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thinking of what you would like to do, you maybe know
who had done it before and you contact and speak to
them, or something like that. (P15)
For most of those interviewed, their experience of
research was gained during postgraduate study where
levels of support varied. A wide range of support needs
were expressed, for example, research design, ethical
guidance, statistics and scientiﬁc writing. This suggests a
widespread lack of experience in HSR despite participa-
tion in postgraduate work and enthusiasm to participate
in research in the NHS. Peer support and research net-
works were also put forward as valuable resources that
could allow pharmacists to identify research opportun-
ities and combine resources to solve practice-related
research questions. The few who had managed to
conduct research within their roles had built their own
support networks:
I’ve more or less just met [collaborators] along the way
and sometimes things produce fruit and sometimes they
don’t. (P17)
Interviewees also cited examples of research activity
that had not resulted in any meaningful output. Failure
to produce and disseminate ﬁndings served only to
reinforce negative views of research and the research
process:
Yes, but we have to be able to share that expertise
and knowledge and we need to basically get it out
there somewhere and, how we do that, I’m not quite
sure. (P21)
I think it’s just getting that initial push and thinking about
publication etc., but I think we’re a bit lost about how to
do that, what journals we should be approaching. (P54)
I think it would be good to [publish]. Usually, if I say I’m
going to do something I’ll do it, but I don’t think I’d be
willing to maybe do it as quickly as I did my write up for
the MSc. (P30)
PHARMACY PROFESSIONAL ISSUES
Pharmacists recognised the importance of supportive
line management to enable research to ﬂourish in their
workplace. Management support was seen as a necessary
pre-requisite to research involvement:
(what is required for research) I think allocated time,
support from your line manager. (P53)
A perceived mixed opinion to research by manage-
ment was due to a potential threat to patient services if
time on clinical practice was reduced:
I am very much part of the clinical team. I am not just
here as a person who oversees everything. I am providing
clinical services as the culture of my job. It restricts the
amount of time that you have at the desk to do other
things. It certainly restricts the amount of time that you
would have to dedicate to research. (P49)
[Research is] very much on the periphery, something
that interests me but I wouldn’t know where to start and
would have a lot of difﬁculty ﬁtting it into my job plan
which is fairly full. (P33)
It’s that bit that’s going to take your average practitioner
away from the wards and away from patients. And when
they’re doing something else like writing something up,
either nobody’s going into that ward, or someone is
having to cover over and above their own ward. There’s
only so much with annual leave, sick leave, mat leave and
everything else that’s going on, there’s only so much
people can manage. (P8)
At a basic level, management support is likely to
involve agreement on a particular research question and
a favourable response to a request by the pharmacist for
protected time to develop a research plan and meet
with potential collaborators. However, this type of discus-
sion, while considered necessary, did not appear to have
taken place in the majority of cases, reinforcing the
belief that the culture was unfavourable or most pharma-
cists were not ready:
You’d have to maybe arrange it… like protected time,
with your manager. You would talk about it and decide if
it was worthwhile or something or see if you can negoti-
ate some sort of time, I would imagine. (P15)
It’s discussions the service haven’t previously had… we
need that recognition of agreement that it is appropriate
for clinical services to dedicate an agreed proportion of
their time to this function and this means that we can
either stop doing something and chase that…I suppose
it’s about perhaps echelons of power within our organisa-
tion, saying “Ok” That’s a commitment we’re saying is
acceptable. (P7)
We haven’t planned in that people will have emm, one
session or a half day a week for their research activity.
And it’s that kind of language that we need to start think-
ing about. (P28)
I think that’s the key… protected time, but we don’t have
the ﬂexibility within the current service to provide that,
as far as I can see. (P43)
One pharmacist took a fatalistic approach while com-
menting on the risks of working up a project only for
more senior colleagues not to support it:
I would be gutted if I did a lot of planning to get the
project ready for [management] to say no. I suppose
that’s inevitable. (P19)
There was some evidence that the passive-receptive
approach to research by management may be due to a
perceived threat to patient services, which were believed
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to be at risk of suffering if pharmacists spent less time
on clinical duties and time on research:
I’ve been told I have to ﬁt [research] into the job. I was
told in no uncertain terms that the job had not to suffer
on the strengths of this, so I had to make time to do it.
(P20)
One divergent view arose, suggesting management
support was adequate:
I’ve been given plenty of opportunities to concentrate on
my research and Manager A is very supportive of…
anyone doing postgrads, so yeah, very encouraging of it,
so yeah, no barriers. (P53)
Receptivity and support of research ideas appeared to
be conditional on aims/objectives aligned with the pri-
orities of pharmacists and their departments.
Pharmacists have support available but are unaware of it
and therefore do not protect the time due to fear and
against the culture of their job:
I would say it’s largely external to the work plan of the
team…I don’t know if we truly integrate any sort of
research attitude to what we do. We have our on work-
place which, as I said, is predominately driven by the
needs of the sector, which can be ﬁnancial. (P25)
Organisational culture appeared to mitigate against
attempts to become research active. Research was not
perceived to be an important factor in the NHS pharma-
cists’ professional career structure, which acted as an
organisational barrier and gave pharmacists no extrinsic
reward for research activity:
Our career progression is towards management
and administration. It is not towards practice and
research. (P5)
The [pharmacy] career framework we’ve got is either
clinical or managerial. [Research] is not seen as a career
objective. (P47)
We get our MSc [students] to do [research] but then I
don’t know… it just doesn’t happen. I suppose there has
been no incentive. (P22)
If [research] was part of [pharmacists’] career develop-
ment, they would be falling over themselves to do
research. (P44)
I think if there isn’t a reward for what you’re doing then
[research] will not be done. (P36)
I mean, [research] is not in my PDP, nothing like that. I
haven’t got any pressure to do research.
Interviewer: Is it in your job description?
It is in the job description. (P22)
Most pharmacists had teaching commitments either
within the NHS or neighbouring universities. For one
pharmacist, a lack of available time on research was as a
consequence of an increase in teaching responsibilities:
Am I involved in research with MScs ? No. Am I involved
in the teaching of the MScs? Yes. Am I involved in teach-
ing undergraduates? Yes. Am I involved in teaching pre
regs? Yes. Am I involved in teaching stage 2 trainees? Yes.
Teaching has mushroomed. Now why has it done that?
Because maybe we appointed very early on, we appointed
education pharmacists, education and training and that
is really…that has blossomed. So we now have far better
education and training, far more in-house training
undergraduates, we take 3rd years, we take 4th years, we
take…all the way through right up to stage 2 training. So,
the teaching has multiplied. (P5)
The need to create capacity through organisational
change was suggested but in practical terms assumed to
be improbable:
If we’re going to create [research active] people at any
level, whether it’s people at senior level like myself, or
even higher, or the troops on the ground, creating cap-
acity is the key. Finding the capability to say “Ok”, as I say,
for example, <NHS Pharmacy> is going to come out of
that… “anyone with a band 8a or 8b has a protected
research component to their job”. How would you
achieve that? (P7)
One interviewee described tacit acceptance among
pharmacists, of the culture of prioritising patient facing
roles above all else, including research:
I think we struggled to get people to take responsibility
for research because to take responsibility is to, we all
have it in our job descriptions and we all know that it’s
probably the one bit of our job descriptions that we’re
failing at, and that’s simply because at some point you’ve
got to make a decision around what you prioritise, and
their core jobs are patient care. (P50)
Other respondents cited multiple contextual barriers,
many of which were considered endemic and
organisational:
I do think about it, but… I don’t feel like line manage-
ment are showing much drive in that direction either.
That’s not to say that I shouldn’t be encouraging it, but
maybe that…maybe the feeling of research as this… you
know, something that we should be doing and I think it
is. Em… if it’s not running entirely throughout our
organisation at the moment then, if there’s no pressure
from beneath, it’s easy to deprioritise it, because there
are things that are important to my team members and
that’s not… it doesn’t seem to be one of them… I
suppose money comes in to it as well. But em… if the
pressure is only from above and within then you want to
do the best thing for your team members, but it doesn’t
seem like something that they are interested in and I
haven’t had the time to sit down and have the same kind
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of conversation that you’re having with me then it just
falls off everybody’s radar. (P37)
People are just ﬁre ﬁghting in the role we have. So,
before we even think about getting more people involved
we need to persuade people it’s the right thing to do,
because I think most people aren’t interested. (P42)
Our hierarchy is not practice or research led, so how can
[individuals in senior roles] expect people below them to
take on that role, when they don’t do it? (P5)
If I was in a research environment… everybody’s mindset
would be the same. We would all be talking about that
sort of thing, and access to the people with [research]
expertise would be there on a day to day basis. So, if you
were having a problem or a question you could go and
get some advice right from the word “go”. Whereas, that
is not readily available. I mean, yes, you can go and ask.
But you have got to go out of your way… (P41)
[Research is] just not seen as part of the job, part of the
routine job, of the pharmacy… I’m aware of the pres-
sures… the management pressures. (P3)
A lot of the new pharmacists probably think that if
they’re interested in research, they will need to pack in
the job and go to University. (P47)
There must be a huge number of Band 7 and Band 8A
who are sitting there doing their job that… could be
stretched further… Would they want to go on and do
something like this? (P39).
OVERALL TRENDS IN REPORTS
To understand the different characteristics of those
involved and not currently involved in research, we com-
pared motivation and barrier reporting of these two
groups. From reports of research involvement and areas
of practice, those reporting least current involvement
mainly worked in general practices (table 2). Overall,
pharmacists reported a higher number of personal
(intrinsic) elements compared to contextual elements
(total frequency of reports 67 vs 46, respectively (table 3)).
Participants currently involved in research reported a
higher proportion of motivational factors than any other
group (table 4).
Nevertheless, across all participants, internal motiva-
tors for research were more frequently reported than
external motivators (total reports of n=49 and 37,
respectively; table 4). In this population, pharmacists
with at least 21 years’ postqualiﬁcation experience were
most likely to be involved in research; those with 11–
20 years’ postqualiﬁcation also had a high proportion of
being currently involved (table 3). However, the group
trends towards the personal barrier aspect, but differs in
motivations. Pharmacists who had been qualiﬁed for
longer, had more contextual motivations than personal
(intrinsic) motivations. This ﬁnding was reversed to
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personal motivations for those who had been qualiﬁed
for less time (table 3).
Overall, this group concurs on barriers to research
being more a personal element, although when we
compare research statuses, those that are not currently
involved in research demonstrate a higher level of con-
textual barriers to research than those currently involved
(table 4).
All these issues have left research culture in pharmacy
severely lacking. In order for research to expand, ser-
vices have to address these issues and push for research
to be an integral part of pharmacy culture.
DISCUSSION
The need for the NHS to meet its objectives by promot-
ing research has been enshrined in policy for over 20
years.51 52 Acknowledging the need to change the status
quo, The Scottish Government’s Prescription for Excellence
(2013) action plan sets out the vision for a new inte-
grated role for pharmacists in Scotland, demanding
‘new ways of thinking, new ways of working and new
models of care’; and HSR is acknowledged as a means
of demonstrating new and established pharmaceutical
care services.4 Pharmacists are aiming for recognition as
clinicians, but in the current healthcare environment
where multidisciplinary teams of specialist and generalist
clinicians provide care through established pathways,
with scarce resources, robust evidence of added value
from pharmacists’ input is needed to change pharmacy
practice in the NHS. This requires the active participa-
tion of NHS employee pharmacists.
Participants expressed an understanding of the rele-
vance, importance and value of research within phar-
macy practice. This, however, did not necessarily lead to
undertaking research. A lack of time was viewed as the
greatest impediment to conducting research. This
served to mask a multitude of factors constraining
research participation, including: prioritisation of clin-
ical services, fear of research encompassing a reluctance
to apply for ethical approval, asking more experienced
clinicians for support or conducting statistical analyses.
A lack of locatable and accessible practical support was
acknowledged. A lack of time (real/perceived) is a con-
sistent theme in the literature.26–29 33–36 53 One study
suggested that ‘time pressure’ has become a socially
acceptable justiﬁcation which healthcare professionals
draw on in order to mitigate responsibilities when their
behaviour is questioned.54
Although there were a variety of experiences and opi-
nions towards research, generally participants reported
that there were more personal than contextual factors
inﬂuencing participation in HSR. When we looked at
barriers reported by those currently and not currently
involved in research, we found that more contextual bar-
riers were reported in those currently not involved. This
suggests that perceived contextual barriers are outweigh-
ing the personal elements to participate in research.
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Individual motives for engaging in research were dis-
cussed in terms of personal and external rewards. Those
actively participating in research or evaluation did so
largely because of potential beneﬁts to the service or
interest in the research area. However, outside a post-
graduate qualiﬁcation, tangible beneﬁts were lacking,
not affecting career development. While rewards may
factor into an individual’s decision to change practice,
they are unlikely to change professional attitudes and
values, that is, the pharmacy culture.55 Perceived lack of
support from senior managers was often cited as a sig-
niﬁcant barrier to research engagement, linked to poor
accessibility to role models, although very few respon-
dents had approached their managers to make the case
for protected time. A lack of conﬁdence to raise the
issue may stem from senior management and pervade
through to lower grades. With longer qualiﬁed pharma-
cists reporting external motivations, it could suggest that
research is more of a personal gain when beginning a
career but becomes part of the job when moving up,
perhaps due to increased autonomy. Priorities often
reﬂected assumptions for patient care, as well as the rela-
tive priority of tasks. Most participants acknowledged
that research was not a priority with clinical service
taking precedence (consistent with survey ﬁndings).28
Pharmacists regarded research as a level of difﬁculty
not associated with their routine jobs; in contrast,
ﬁnding time and prioritisation appeared less of a
problem when research was within the postgraduate
qualiﬁcation context: research is tightly managed and
time limited by university tutors. Given the lack of conﬁ-
dence and competence to starting and leading research,
this highlights the importance of adequate, accessible
practical research support in the workplace. Our results
suggest that an underlying fear of failure or movement
out of a comfort zone, created by practice culture and a
lack of incentive, may account for the low uptake.
Our ﬁndings compare with previously published evi-
dence gathered over the past 20 years involving pharma-
cists in community pharmacies and show common
barriers to participation in research. These include time
constraints;34 37 53 56 reports of being too busy attending
to patients’ needs;37 questionable motivation;37 57 and a
lack of experience and training.33 34 We found that phar-
macists employed by the NHS and community pharma-
cists also shared perceptions of the importance of
research, and both groups struggled to incorporate
research into practice.34 37 42 Unlike community phar-
macists, research activity forms part of the job role of
NHS employee pharmacists; however, we found this
apparent advantage to be insufﬁcient to ensure the prac-
tice of research in the majority of cases. Teaching is
included in NHS employee pharmacists’ work plans, and
routinely delivered, whereas research is in job descrip-
tions, but rarely in work plans or delivered. Traditional
teaching methods and research both reduce patient
contact, but teaching is accepted while research is not
prioritised. By implication, there may be a need to revise
the organisational and cultural environment around
these activities, if research is to ﬂourish. The explicit
inclusion of research into NHS employee pharmacists’
job roles, personal development and appraisal may
encourage research activity, while also having the advan-
tage of linking research to career progression and
forcing a conversation about research between pharma-
cists and their line managers.
The multidisciplinary environment within which
hospital-based and general practice-based pharmacists
work, in theory, might be regarded as optimal to
conduct HSR, in comparison to the relative professional
isolation experienced by community pharmacists.
However, only highly motivated individuals had taken
the opportunity to collaborate and develop research
active networks, perhaps because pharmacists lacked
conﬁdence and perceived themselves as not sufﬁciently
competent in research, a ﬁnding from previous work
involving hospital pharmacists in Thailand.41 Others
may have feared rejection, or venturing into unfamiliar
territory, thereby jeopardising professional relationships
with peers or practitioners from other disciplines.
The few pharmacists who had managed to incorporate
research into their roles appeared to draw on their
internal drive to conduct research, rather than their job
role or other external incentives, for example, demands
from their peers, managers or pursuit of career progres-
sion. One implication of this ﬁnding is that sufﬁciently
motivated individuals will be able to overcome obstacles
that others ﬁnd limit research activity. Peer-to-peer dis-
cussion involving research active pharmacists with
research inactive pharmacists may therefore offer a
means of improving the uptake of research in pharmacy
in the NHS.
Most of the NHS pharmacists interviewed either had
previously undertaken or were currently undertaking
research in part fulﬁlment of a workplace-based post-
graduate pharmacy qualiﬁcation, which includes a
research component. Commonly, the qualiﬁcation is a
Master of Science in Clinical Pharmacy. A relevant post-
graduate qualiﬁcation is necessary for career progression
in NHS Pharmacy. Given the high proportions of partici-
pants with research experience, the emergence of lack of
competence as an impediment to undertaking research
suggests that the learning received during postgraduate
qualiﬁcation did not equip pharmacists for the subse-
quent practice of research in the workplace. Further
exploration of the reasons for this are required to enable
research learning to translate into practice. In addition, it
appears that if research participation became a pre-
requisite to career progression, uptake would most likely
increase. In comparison, the medical profession has
incentivised research participation by linking it to career
progression, suggesting that the creation of clinical
research posts would encourage increased engagement
by a greater number of pharmacists.
As far as we are aware, only one previous study, pub-
lished over 25 years ago, examined research activity by
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experienced NHS hospital pharmacists in the UK.36
Through questionnaires and interviews, the authors
found that most projects had been initiated as part of an
imposed postgraduate (or pre-registration) project. The
majority regarded research as a low priority, with time
presenting the biggest barrier, and insufﬁcient expertise.
These ﬁndings resonated with ours, suggesting that
pharmacy and pharmacists’ reasons for low research
uptake are endemic and persistent. The career structure
of pharmacy in the NHS has not changed signiﬁcantly
during this period; however, the need for more robust
evidence to inform pharmacy practice has increased
because of the prevailing ﬁscal climate. A revision to
NHS pharmacists’ career structure may be needed if
employees are to establish new ways of working through
robust evidence of effectiveness and cost-effectiveness, in
a spirit of self-determination and self-reliance.
Our ﬁndings, which included the perceptions of
primary care-based pharmacists, may be seen in the
context of research activity being problematic for other
healthcare professionals, particularly in primary
care.58–60 For many, it appears there are multiple and
competing priorities preventing participation, suggesting
the need for a multifaceted approach (including struc-
tural and individual elements) to increase activity.
Salmon et al describe research as an alien ﬁeld for physi-
cians, and a lack of time for research was reported by
nurses.54 61 Given the perception held by physicians and
nurses, together with the pervasive themes describing
multiple difﬁculties associated with research participa-
tion emerging from our ﬁndings, it may be the case that
generation of evidence-based working practices through
HSR will remain the preserve of a few highly motivated
individuals.
Positive and negative views were expressed within each
theme with unanimously positive expressions in the
minority. Participants who were not research active
tended to describe a pattern of obstacles conspiring to
prevent activity. These included professional issues, a
reluctance to seek practical help and expressed lack of
conﬁdence and competence. However, for a small
number of motivated participants, research had found a
place in their existing value systems and job roles,
actively competing with work and personal life priorities,
reﬂected by a willingness to re-negotiate working hours
with management to free up time for research and a vig-
orous defence of planned research time. This suggests
that a minority of pharmacists can ‘ﬁnd the time’ where
research is valued, while tacitly accepting the need to
spend additional time on research.
The lack of research in pharmacy culture is a combin-
ation of contextual barriers that may be based on fear
and going against the normal culture, and a more indi-
vidual element such as lack of conﬁdence or poor time
management. The introduction of multifaceted changes
at the organisational level that offer practical, accessible
support for committed individuals may gradually lead to
a reappraisal of how best to use non-patient facing time.
In the short term, however, it may be necessary to incen-
tivise the process to produce a cultural shift that sees the
majority of pharmacists move from their current
research inactive position into one of research activity.
Our ﬁndings may be weakened by several methodo-
logical factors. All participants were drawn from one
NHS organisation, which may differ from others in rela-
tion to employees and context. However, our organisa-
tion is the largest in the UK, and pharmacists’ roles and
responsibilities are shared across the NHS. There may
have been an implicitly positive view of research in the
questioning, particularly as pharmacists were asked why
they had not participated. As the study focused on per-
ceptions of research, in theory, participants may have
been vulnerable to the social desirability effect. Although
generalisations cannot be inferred from our ﬁndings,
our ﬁndings do represent the views of NHS employee
pharmacists, and can be used to stimulate further work.
CONCLUSION
HSR for most pharmacists, for multiple reasons, was
viewed as an exceptional activity rather than a core role.
In order to develop and test sustainable, new models of
pharmacists working in relation to patient beneﬁt and
answer calls for innovation, pharmacists may need to let
go of their research related fears and modify what may be
regarded as a restrictive professional NHS environment.
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